Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations

Blood Cancer Journal, Published online: 17 February 2023; doi:10.1038/s41408-023-00799-6Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations

Source: Blood Cancer Journal - February 17, 2023 Category: Hematology Authors: Yuxuan Che Yang Liu Yixin Yao Holly A. Hill Yijing Li Qingsong Cai Fangfang Yan Preetesh Jain Wei Wang Lixin Rui Michael Wang Source Type: research